Cloning and high level expression of a chimeric antibody with specificity for human carcinoembryonic antigen.
Open Access
- 1 December 1988
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 141 (11) , 4053-4060
- https://doi.org/10.4049/jimmunol.141.11.4053
Abstract
A mouse/human chimeric antibody has been constructed by using variable light and variable heavy regions from a murine hybridoma specific for human carcinoembryonic antigen (CEA) (CEM231.6.7). These V regions were combined with kappa and gamma-1 constant region genes cloned from human lymphocytes. The chimeric constructs were sequentially electroporated into murine non-Ig-producing myeloma (P3.653) and hybridoma (SP2/0) cell. Significant differences were seen in expression levels between the two cell types. High levels of expression (24 to 32 micrograms/ml/10(6) cells) were seen with several of the anti-CEA SP2/0 transfectomas but not with the P3.653 cells. The SP2/0 transfectoma lines were adapted to serum-free, chemically defined media and grown in large scale fermentation cultures where they continued to secrete high levels of antibody. The chimeric antibodies remain reactive against human CEA with affinity constants comparable to that of the parental hybridoma antibody. High level expression will make practical the production of chimeric antibodies for in vivo therapeutic and diagnostic purposes.This publication has 22 references indexed in Scilit:
- Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.Proceedings of the National Academy of Sciences, 1985
- A SYSTEMATIC-APPROACH FOR DETECTING HIGH-FREQUENCY RESTRICTION FRAGMENT LENGTH POLYMORPHISMS USING LARGE GENOMIC PROBES1985
- HUMAN ANTI-MURINE IMMUNOGLOBULIN RESPONSES IN PATIENTS RECEIVING MONOCLONAL-ANTIBODY THERAPY1985
- Determination of the relative positions of amino acids by partial specific cleavages of end-labeled proteinsBiochemistry, 1985
- Recombinant antibodies possessing novel effector functionsNature, 1984
- Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation.Proceedings of the National Academy of Sciences, 1984
- Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.Proceedings of the National Academy of Sciences, 1984
- DIAGNOSIS OF AND THERAPY FOR SOLID TUMORS WITH RADIOLABELED ANTIBODIES AND IMMUNE FRAGMENTS1984
- COVALENT BINDING OF METHOTREXATE TO IMMUNOGLOBULINS AND THE EFFECT OF ANTIBODY-LINKED DRUG ON TUMOR-GROWTH INVIVO1981
- Semi-automatic solid-phase radioimmunoassay for carcinoembryonic antigenJournal of Immunological Methods, 1977